Product Benefits

• Superior Antiviral Efficacy: Nexataf 25mg contains Tenofovir Alafenamide (TAF), a highly effective antiviral that inhibits the replication of the Hepatitis B virus (HBV), significantly reducing viral load.

• Enhanced Safety Profile: Designed to deliver the active drug more efficiently to liver cells, allowing for a lower dose that is much safer for the kidneys and bones compared to older versions of Tenofovir (TDF).

• Targeted Delivery: It specifically targets the liver, ensuring that the medication reaches the site of infection with minimal systemic exposure, reducing the risk of long-term side effects.

• Prevents Liver Damage: Consistent use helps prevent the progression of Hepatitis B to more serious conditions such as liver cirrhosis or hepatocellular carcinoma (liver cancer).

• Bone Health Protection: Clinical studies show that patients taking TAF experience significantly less impact on bone mineral density, making it a better choice for long-term therapy in aging patients.

• Kidney Friendly: Offers a improved renal safety profile, making it suitable for patients with mild to moderate kidney concerns who require chronic antiviral treatment.

• Once-Daily Convenience: The simple 25mg once-a-day tablet format improves patient adherence, ensuring the virus remains suppressed throughout the day.